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Human embryonic stem cells (hESCs) can survive
and proliferate for an extended period of time in cul-
ture, but unlike that of tumor-derived cells, this form
of cellular immortality does not depend on genomic
aberrations. In this study, we sought to elucidate
themolecular basis of this long-term growth property
of hESCs. We found that the survival of hESCs de-
pends on the small GTPase Rho and its activator
AKAP-Lbc. We show that AKAP-Lbc/Rho signaling
sustains the nuclear function of the transcriptional
cofactors YAP and TAZ by modulating actin microfil-
ament organization. By inducing reprogramming and
differentiation, we found that dependency on this
Rho signaling pathway is associated with the plurip-
otent state. Thus, our findings show that the capacity
of hESCs to undergo long-term expansion in vitro is
intrinsically coupled to their cellular identity through
interconnected molecular circuits that link cell sur-
vival to pluripotency.
INTRODUCTION
Embryonic stem cells (ESCs) have the potential to give rise to
cells of all three germ layers, a characteristic known as pluripo-
tency (Nichols and Smith, 2012). They provide an excellent
in vitro system to understand early mammalian developmental
processes including cell differentiation or fate determination. In
addition, human pluripotent stem cells, including human ESCs
(hESCs) and induced pluripotent stem cells (hiPSCs), hold great
potential as replenishable resources for the development of cell
therapies and for use in drug discovery (Murry and Keller, 2008).
Extensive studies of the molecular basis for the establishment
and maintenance of pluripotency have revealed that intrinsic
and environmental factors, such as growth factors and cell-
cell/cell-matrix signals, coordinate to regulate the pluripotency
network by fine-tuning the activity of a defined set of transcrip-
tional factors and epigenetic modifiers (Nichols and Smith,
2012).448 Cell Stem Cell 17, 448–461, October 1, 2015 ª2015 Elsevier Inc.ESCs are able to undergo long-term expansion in culture, a
phenomenon that is orchestrated by the sustainable proliferation
and survival of individual cells. Such ‘‘immortality’’ is observed
only in ESCs and cancer cells, and sharply contrasts with pri-
mary cultured normal cells, which can be expanded for only
limited periods in vitro before undergoing senescence or death
(Schmitt, 2003). The in vitro expansion of tumor-derived cells is
known to be strictly dependent on multiple genetic mutations,
which irreversibly cause misactivation in oncogenes or dysfunc-
tion in tumor suppressors. ESCs, on the other hand, exhibit long-
term expansion while retaining a normal karyotype. Importantly,
ESCs lose this property during differentiation, demonstrating the
plasticity of their immortal phenotypes. Although some of the
mechanisms that overcome barriers to unlimited growth in
mouse ESCs have been reported (Takahashi et al., 2003; Zalz-
man et al., 2010), the mechanism by which hESCs adapt to
ex vivo environments and undergo long-term expansion remains
unknown.
We previously reported that the small GTPase Rho promotes
cell death of dissociated hESCs via ROCK-dependent myosin
hyperactivation (Watanabe et al., 2007; Ohgushi et al., 2010).
In the present study, we introduce an unexpected aspect
of Rho function, namely that Rho signaling is required for the
survival and expansion of hESCs cultured en bloc. This raises
the possibility that the Rho pathway plays culture context-
dependent roles in hESCs. To understand the molecular mech-
anisms underlying this finding, we sought to answer the
following questions: Which aspect of Rho signaling is rele-
vant for survival? Which downstream pathways are involved
in the Rho-mediated survival promotion? How is the depen-
dency of hESC survival on Rho signaling related to the pluripo-
tent state?
To characterize the pro-survival activity of the Rho signaling
pathway, we performed a candidate functional screen and
identified AKAP-Lbc, a Rho activator, as essential for hESC
survival. We further identified YAP and TAZ as major down-
stream factors in the pro-survival Rho signal pathway (YAP
and its paralog TAZ are transcriptional cofactors; for simplicity,
we refer to them as a YAP/TAZ). We then found that actin dy-
namics transmit the AKAP-Lbc/Rho signal to regulate YAP/TAZ
function. Finally, we found that the dependency of cultured
hESCs on Rho signaling is specifically connected to pluripotent
cellular identity.
RESULTS
Rho Activity Is Required for hESC Survival
Small GTPases in the Rho subfamily (RhoA, RhoB, and RhoC in
mammal) function as molecular switches cycling between
guanosine diphosphate (GDP)-bound inactive and guanosine
triphosphate (GTP)-bound active forms (Burridge and Wenner-
berg, 2004). We previously showed that inhibition of ROCK or
myosin, downstream effectors of Rho, promotes the survival of
dissociated hESCs (Watanabe et al., 2007; Ohgushi et al.,
2010). We therefore reasoned that Rho inhibition might have a
similar pro-survival effect. Contrary to this expectation, however,
we found that treatment of KhES-1 hESCswith a Rho-specific in-
hibitor C3 (Morii et al., 1990) resulted in massive cell death within
24 hr, even under non-dissociation conditions (Figure 1A and
Movie S1, part1). Prior to cell death, cell morphology was
strongly altered within several hours (Figures 1A and 1B). Quan-
titative analyses indicated that after 24 hr treatment with C3,
most of the cells became positive for a cell death marker (Fig-
ure 1C; representative flow cytometric histogram was shown in
Figure S1A). This cell death also occurred in the presence of a
ROCK inhibitor (Y-27632; Figure 1C) and in another hESC line
(KhES-3; Figure S1B). Notably, overexpression of anti-apoptotic
Bcl-XL effectively inhibited cell death (Figures S1C and S1D),
indicating that the response was driven through an active
signaling process rather than an uncontrolled cellular collapse.
We next examined the role of Rho in hESC survival more strin-
gently using drug-inducible RNAi-knockdown (see Figures S1F
and S1G for the strategy). Following this strategy, we obtained
a polyclonal population in which each Rho isoform could be
effectively and selectively depleted in an optional timing (Fig-
ure 1D; note that RhoB protein is effectively undetectable in our
hESC line; Figure S1E). Hereafter, we denote these engineered
hESCs as ‘‘tet-sh[Target]’’ (for instance, tet-shRhoA). Doxycy-
cline (dox)-induced depletion of RhoA and RhoC reduced the
expansion of alkaline phosphatase (AP)-positive colonies (Fig-
ures 1E, 1F, and S1H show the entire view of the stained plate).
In particular, RhoC depletion almost totally eliminated growing
colonies from the culture. These phenomena were also seen in
a feeder-free culture condition (on Matrigel substrate in mTeSR1
media; Figure S1I) and confirmed by time-course quantitative an-
alyses (Figure 1G). Using live imaging, we observed cell death
upon RhoC depletion (Figures 1H and S1J for control; quantita-
tive data were shown in Figure 1I; Movie S1, part 2), suggesting
that defective colony expansion is caused mainly by cell death
rather than by proliferation defects or differentiation.
Thus, Rho activity—that of RhoC in particular—is required for
hESC survival. Our previous study showed that E-Cadherin-
mediated cell-cell contact prevents cellular Rho activity from
being aberrantly activated (Ohgushi et al., 2010). Our new obser-
vations suggested the interesting possibility that Rho acts as a
survival factor in these conditions.
AKAP-Lbc Is a Rho-GEF Responsible for the
Rho-Mediated Survival Signal
The Rho pathway is controlled by the cooperation of a large
number of distinct types of modulators, GEFs (activators),
GAPs (inactivators), and GDIs (inhibitors) (Burridge and Wenner-
berg, 2004; Bos et al., 2007). The large diversity of regulators andCeeffectors may enable context-specific distinct Rho functions.
Given the dual role of Rho in cell survival, we speculate that mul-
tiple Rho signaling pathways are active in hESCs. We previously
found that a specific GEF ABR activates the pro-apoptotic Rho/
ROCK/Myosin pathway following cellular dissociation (Ohgushi
et al., 2010). With this in mind, we hypothesized the presence
of a unique GEF factor that specifically acts in the pro-survival
Rho pathway.
We first evaluated the mRNA expression of known Rho iso-
form-activating GEFs (Rossman et al., 2005) (Figure S2A) and
focused on 22 candidates whose expression was detected in
both hESC and hiPSC lines. To identify the factor(s) involved in
hESC survival, we performed a small-scale RNAi screen (Fig-
ure 2A) and found that the expression of a short hairpin (sh)
RNA against AKAP13 strongly suppressed AP+ colony expan-
sion (Figures 2B and S2B), a phenotype that was reversed by co-
expression of an active RhoC mutant (Figure S2C). Although it
has been reported that AKAP13 produces several Lbc protein
isoforms (Olson et al., 1997; Diviani et al., 2001; Figure S2D),
western blotting analyses revealed that hESCsmainly expressed
one AKAP-Lbc isoform (Figure S2E). The reliability of this
screening result was confirmed by the drug-inducible RNAi strat-
egy described above (Figures 2C, 2D, 2F, and S2G; in figures,
the engineered hESCs are labeled as a ‘‘tet-shLbc’’, instead of
the full protein name AKAP-Lbc). Similar phenotypes were
observed when another shRNA was used and were seen in
another hESC line and in feeder-free culture (Figures S2F–
S2H). The expansion defect was also verified by time-course
growth analyses (Figure 2F). Similar to the case of RhoC, loss
of AKAP-Lbc caused cell death that could be reversed by Bcl-XL
overexpression (Figures 2G and 2H and Movie S2), indicating
that this GEF factor is required for hESC survival.
AKAP-Lbc is a very large protein (over 2,800 amino acids) con-
taining a Rho-GEF domain (DH/PH) and a PKA-anchor domain
(Figure S2C) (Diviani et al., 2006). To examine the relationship be-
tween AKAP-Lbc and Rho, we performed rescue experiments.
Overexpression of an RNAi-resistant AKAP-Lbc mutant (AKAP-
Lbc*) substantially suppressed cell death in AKAP-Lbc-depleted
hESCs, but a GEF-dead mutant form (AKAP-Lbc*(YF); Diviani
et al., 2001) had little effect (Figures S2I and S2J), indicating
that AKAP-Lbc controls hESC survival by activating the Rho-
mediated signal pathway.
Immunostaining analyses showed that AKAP-Lbc is distrib-
uted in the cytosol in a punctate pattern (Figures 2I, 2J, S2L,
and S2K show antibody specificity). Structured illumination mi-
croscope (SIM) images showed that some of AKAP-Lbc proteins
partially colocalize with F-actin (Figure 2K), as demonstrated in
previous studies (Olson et al., 1997; Diviani et al., 2001). z axis
scanning along the apical-basal axis using confocal imaging indi-
cated that AKAP-Lbc distribution is biased to the basal side, with
little signal at the apical (Figures 2L and S2M and Movie S3).
Collectively, these data suggest that AKAP-Lbc, a basally
localized Rho-GEF, is responsible for the survival-supporting
axis of Rho signaling.
Transcriptional Cofactor YAP/TAZ Is Attenuated in
AKAP-Lbc-Depleted hESCs
To search for the specific intracellular pathways that are affected
by AKAP-Lbc-depletion, we compared gene expression inll Stem Cell 17, 448–461, October 1, 2015 ª2015 Elsevier Inc. 449
Figure 1. Rho Activity Is Required for hESC Survival
(A) Live imaging analyses of KhES-1 cells treated with C3 (2 mg/ml) for 24 hr. The dead cells were visualized with Propidium iodide uptakes (red, bottom). The
recording was started immediately after the dox addition. The scale bar represents 100 mm.
(B) Immunostaining of KhES-1 cells treated with or without C3 for 8 hr. The OCT3/4 (green) and F-actin (red) were shown. The scale bar represents 200 mm.
(C) Cell death assay. The KhES-1 cells were cultured with or without C3 for 24 hr and the percentage of DRAQ7-positive dead cells was determined by flow
cytometric analyses.
(D) Western blotting analyses. The engineered KhES-1 cells, indicated as tet-shCont (for control), tet-shRhoA (for inducible depletion of RhoA), and tet-shRhoC
(for inducible depletion of RhoC) were cultured with or without dox for 3 days. The HSC70 was examined as a loading control.
(E) Colony expansion assay. The left images show colony morphology before the dox addition (day 0). The right images were obtained after 5 days culture in the
presence or absence of dox (day 5). The colonies were visualized by AP staining. The scale bar represents 500 mm.
(F) Area occupancy of AP positive colonies within each stained well at day 5.
(G) Time course quantitation of living cells after dox addition. In this case, cells were maintained on Matrigel with MEF-conditioned medium.
(H) Live imaging of dox-treated tet-shRhoC KhES-1 cells. The dead cells were visualized with YOYO-1 uptakes (green, bottom). The recording was started from
24 hr after dox addition. The scale bar represents 200 mm.
(I) Cell death assay. The indicated cells were cultured with or without dox for 3 days.
The bars in the graphs represent SD (Student’s t test, n = 3, n.s., not significant, and ***p < 0.001 in C, F, and I). See also, Figure S1 and Movie S1.control and AKAP-Lbc-depleted hESCs by RNA-sequencing
analysis (Figure 3A). Taking into account the concern that several
pathways could be perturbed by death-associated secondary
effects, masking primary responses, we overexpressed Bcl-XL
to preserve the transcriptional profile that exists before cata-
strophic activation of a cytolethal program in the AKAP-Lbc-450 Cell Stem Cell 17, 448–461, October 1, 2015 ª2015 Elsevier Inc.depleted population. From this analysis, we identified 166 genes
that were significantly up (Log2 fold > 2) or downregulated (Log2
fold <2) after AKAP-Lbc-depletion (Figure 3B; Table S1). Look-
ing at the downregulated genes, we found that two of the top ten
genes with the highest fold-change, CTGF and AMOTL2, were
known target genes of the transcriptional cofactor YAP/TAZ
Figure 2. AKAP-Lbc Is a Rho-GEF Essential for hESC Survival
(A) Schematic of the RNAi screening experiments. This procedure was based on the prediction that depletion of responsible GEF may phenocopy the Rho
inhibition. The cells were transiently transfected with each shRNA plasmid. After eliminating non-transfected cells by puromycin treatment, surviving cells were
visualized by AP staining.
(B) Screening result is summarized by area occupancy of the AP-positive cells. The LacZ or RhoC knockdown was a negative and positive control, respectively.
(C) Western blotting analyses. The tet-shCont and tet-shLbc KhES-1 cells (for inducible depletion of AKAP-Lbc) were cultured with or without dox for 3 days. The
HSC70 was examined as a loading control.
(D and E) Colony expansion assay (D) and area occupancy of AP-positive colonies (E). The scale bar represents 500 mm.
(F) Time course quantitation of living cells after dox addition.
(legend continued on next page)
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(Zhao et al., 2008; Mohseni et al., 2014). Quantitative (q)PCR
analyses validated the decreased expression of CTGF and
AMOTL2, as well as CYR61, another representative target
gene (Lai et al., 2011) (Figure 3C). These data suggest that there
may be YAP/TAZ dysfunction in AKAP-Lbc-depleted cells.
YAP/TAZ has been shown to promote cell proliferation and
survival in several experimental systems, so we regarded these
factors as good candidates for downstream effectors in the pu-
tative survival-promoting signaling pathway. In hESCs, YAP/TAZ
is predominantly distributed in the nucleus (Figures S3A–S3C)
and associated with TEAD1, a nuclear partner of YAP/TAZ (Fig-
ure S3D), consistent with active function as transcriptional
cofactors. Next, we examined whether AKAP-Lbc-depletion
affects YAP/TAZ behavior. Western blot analyses showed that
protein levels of both YAP and TAZ were reduced in AKAP-
Lbc-depleted cells (Figure 3D). In addition to transcriptional
downregulation, there may have been enhanced protein degra-
dation, as TAZ protein levels were restored in the presence of
a proteasome inhibitor (Figures S3E and S3F). In addition, the re-
sidual YAP/TAZ was delocalized and showed reduced nuclear
localization (Figures 3E, 3F, S3G, and S3H). Identical results
were obtained in another hESC line (Figures S3I and S3J). These
data indicate that this GEF is required for the function of YAP/
TAZ as transcriptional cofactors.
To investigate whether YAP/TAZ has any impact on hESC sur-
vival and expansion, we performed RNAi-mediated loss-of-func-
tion experiments for YAP/TAZ (Figures 3G, S3K, and S3L show
the functional control experiments for our double knockdown
strategy). Depletion of either YAP or TAZ alone partially reduced
colony expansion. In particular, YAP depletion had only a mar-
ginal effect. However, simultaneous depletion of both proteins
caused a dramatic decrease in colony expansion (Figures 3H,
3I, and S3H) that was reproduced in other experimental set-
ups (Figures S3N–S3P). YAP/TAZ double knockdown caused
cell death that was rescued by Bcl-XL (Figures 3J and 3K and
Movie S4), as well as an RNAi-resistant TAZ (Figure S3Q).
These results indicate that YAP/TAZ is functionally compro-
mised in AKAP-Lbc-depleted hESCs, which may explain the
defective survival and expansion of these cells.
YAP/TAZ Attenuation Is a Major Cause for the Impaired
Survival of AKAP-Lbc-Depleted hESCs
To ascertain whether YAP/TAZ attenuation was a direct cause of
the cell death, rather than merely an unrelated epiphenomenon
or an artifact of the death-suppressive conditions, we performed
rescue experiments by promoting YAP/TAZ activity.
YAP/TAZ attenuation is often correlated with activation of the
Hippo signaling pathway (Yu andGuan, 2013). This evolutionarily
conserved pathway activates the kinases LATS1 and LATS2(G) Live imaging analyses of dox-treated tet-shLbc KhES-1 cells. The dead cells w
from 24 hr after dox addition. The scale bar represents 200 mm.
(H) Cell death assay. The indicated cells were treated with dox or not for 3 days.
were also examined.
(I–L) Immunostaining for AKAP-Lbc. (J) Confocal images. (K) Super-resolution S
apical-to-basal axis. The top, middle, and bottom represent most-apical, sub-apic
OCT3/4 (red in I), F-actin (red in K), and E-cadherin (red in L) were shown. The sc
The bars in the graphs represent SD. The Student’s t test (n = 3) (E); Dunnett’s
Figure S2 and Movies S2 and S3.
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phosphorylates YAP/TAZ at several residues, priming YAP/TAZ
for inhibition by at least two mechanisms: cytoplasmic seques-
tration by anchoring proteins such as 14-3-3, which is triggered
by N terminus phosphorylation, and proteolytic degradation,
which is primed by phosphorylation at the C termini (Figure 4A;
Yu and Guan, 2013). We examined the magnitude of Hippo
pathway activation in AKAP-Lbc-depleted cells and found that
substantial elevation of YAP, MST1/2, or LATS1/2 phosphoryla-
tionwas not observed (Figure 4B). Consistent with this, an in vitro
kinase assay revealed that LATS activity is not substantially
altered (Figure 4C). These results indicate that AKAP-Lbc-deple-
tion does not elevate LATS activity or, alternatively, that LATS is
already active before AKAP-Lbc-depletion.
To address whether this observed LATS activity affected the
attenuation of YAP/TAZ, we simultaneously depleted AKAP-
Lbc and LATS (Figure 4D; triple knockdown strategy was shown
in Figure S4A). As expected, the YAP phosphorylation level was
reduced by LATS1 and LATS2 double knockdown (Hippo-OFF
condition, see below). In a colony expansion assay, LATS inhibi-
tion caused no significant increase relative to AKAP-Lbc-
depleted cells (Figures 4E, 4F, and S4B). Consistently, YAP/
TAZ delocalization and dysfunction were not substantially
reversed by reducing LATS expression (Figures 4G and S4D).
Thus, YAP/TAZ activity was still depressed even without priming
by LATS-mediated phosphorylation, indicating that YAP/TAZ
attenuation in AKAP-Lbc-depleted hESCs occurs in a LATS-
independent manner.
Because YAP/TAZ function is not restored by derepression
strategies, including LATS knockdown (Figures 4E and 4F) or
overexpression of LATS-insensitive TAZ (Figure S4C), we next
performed a direct gain-of-function study of TAZ (TAZ has
more prominent effects on hESC survival than YAP, Figure 3I).
To achieve enforced TAZ activation, we utilized ERT2-TAZ, a
fusionmolecule that can be localized to the nucleus by 4-hydrox-
ytamoxifen (4OHT) exposure (Figures S4E and S4F; Indra et al.,
1999). We confirmed that 4OHT promotes nuclear accumulation
of ERT2-TAZ and transcriptional activation of CTGF and CYR61
(TAZ-ON condition, Figures S5G and S5H). However, when
4OHT was added, only a few small AP+ colonies formed in the
AKAP-Lbc-depleted cells (Figures 4H, 4I, and S4I).
Considering the possible inhibitory function of LATS in TAZ
activation, we next tested TAZ gain of function combined with
LATS loss of function by expressing TAZ or ERT2-TAZ in the tet-
shLbc/Lats hESCs (TAZ-ON/Hippo-OFF). Interestingly, a simple
overexpressionof TAZunder theHippo-OFFcondition resulted in
a subtle, but significant, rescue on AP+ colony expansion. More
importantly, forced TAZ activation using ERT2-TAZ + 4OHT
showed a more dramatic increase in colony expansion (Figuresere visualized with YOYO-1 uptakes (green, bottom). The recording was started
The Bcl-XL-expressing tet-shLbc KhES-1 cells (referred as a tet-shLbc:Bcl-XL)
IM images. Both images show medial sections. (L) Z-scanning images along
al, and most-basal sections, respectively. The AKAP-Lbc (green in all images),
ale bars show 100 mm (I), 50 mm (J), and 10 mm (K and L), respectively.
test (n = 3) versus lane 2 (H); not significant (n. s.); and ***p < 0.001. See also
(legend on next page)
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4J, 4K, and S5J). Consistent with these results, total and nuclear
abundance of ERT2-TAZ recovered nearly to the control level un-
der the TAZ-ON/Hippo-OFF condition (data not shown). Thus,
forced TAZ activation rescues AKAP-Lbc-depletion-induced
phenotypes when supported by Hippo pathway inactivation.
In conclusion, our data provide strong evidence that YAP/TAZ
attenuation plays a major role in the impaired survival of AKAP-
Lbc-depleted hESCs.
Role of the Hippo Pathway in YAP/TAZ Control
Some of the results regarding interaction between LATS and
YAP/TAZ activity are somewhat difficult to reconcile. LATS inhi-
bition failed to restore YAP/TAZ function in AKAP-Lbc-depleted
cells (Figures 4E and 4G), clearly indicating that YAP/TAZ is in-
hibited by a LATS-independent mechanism in this experimental
condition. However, LATS knockdown is required for TAZ-medi-
ated rescue of AKAP-Lbc-depleted cells (Figures 4J and 4K),
suggesting that LATS does nevertheless counteract ERT2-TAZ
nuclear accumulation in this context. These results may reflect
the existence of multiple redundant regulatory mechanisms for
YAP/TAZ regulation in hESCs.
Notably, contact-dependent LATS activation (Figure S4L) and
LATS-mediated YAP phosphorylation (Figure S4K) were clearly
detected, suggesting that the Hippo kinase cascade is activated
in growing hESC colonies to a level sufficient for this to occur. In
this regard, we noted an intriguing behavior of YAP in hESCs;
despite the expectation that phosphorylated YAP is excluded
from nuclei, immunostaining using a phospho-YAP antibody ex-
hibited nuclear signals as well as faint cytosolic ones (Figures
S4M and S4N show biochemical analyses). Thus, LATS phos-
phorylates YAP/TAZ, but does not impede its nuclear localiza-
tion unless the AKAP-Lbc/Rho pathway is inhibited, suggesting
that LATS is a modulator, but not a main determinant, of YAP/
TAZ function in this context.
Taken together, our data indicate that the AKAP-Lbc/Rho
pathway regulates YAP/TAZ behavior via a LATS-independent
mechanism.
The Contribution of F-Actin Dynamics in AKAP-Lbc/
Rho-Mediated Survival Signal Transduction
Next, we sought to identify the mechanistic connection between
AKAP-Lbc/Rho and YAP/TAZ. Recent studies suggested micro-Figure 3. Transcriptional Cofactor YAP/TAZ Is Attenuated in AKAP-Lb
(A) Schematic of RNA-seq analyses. The Bcl-XL-expressing cells (tet-shLbc:Bcl-
(B) Genes identified by the RNA-seq experiment. The two red dots show AMOTL
(C) qPCR assay for YAP/TAZ target genes. The tet-shLbc:Bcl-XL KhES-1 cells w
(D) Western blotting analyses for YAP/TAZ in control and AKAP-Lbc-depleted Kh
(E) The tet-shLbc:Bcl-XL KhES-1 cells were treated or not with dox for 3 days and s
were obtained with a confocal microscopy. The bottom images show the enlarg
(F) Quantification of nuclear YAP/TAZ abundance by confocal image data proce
(G) Western blotting analyses. The engineered KhES-1 cells, indicated as tet-
depletion of TAZ), and tet-shYAP/TAZ (for simultaneous inducible depletion of YA
as a loading control.
(H and I) Colony expansion assay (H) and area occupancy of AP-positive colonie
(J) Live imaging analyses of tet-shYAP/TAZ KhES-1 cells during 24–72 hr period o
bottom). The scale bar represents 200 mm.
(K) Cell death assay. The indicated cells were cultured with or without dox for 3 da
examined.
The bars in the graphs represent SD. Student’s t test (n = 3) (C and F); Durnett’ test
***p < 0.001. See also Figure S3 and Movie S4; Table S1.
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2011; Zhao et al., 2012; Aragona et al., 2013). Of interest, impres-
sive morphological alterations occurred in death-suppressed
hESCs after AKAP-Lbc was depleted (Figures 5A and 5C).
Although hESC colonies show a typical epithelial-like mor-
phology polarized along the apical-to-basal axis (Figure S5A),
upon AKAP-Lbc-depletion, irregular gaps spontaneously arose
inside the hESC epithelial sheet, leading the colony to split into
several fragments (Figure 5A andMovie S5, part 1). In these frag-
mented colonies, epithelium-characteristic microfilament struc-
tures (e.g., apical actin bundle) disappeared and they piled up
into a disorganized cell mass (Figures 5B and 5C and Movie
S5, part 2). To study this process in more detail, we focused
on F-actin organization in the basal area, as AKAP-Lbc localiza-
tion has a basal bias and it may be associated with actin fila-
ments (Figures 2K and 2L). Immunostaining showed numerous
thick stress fibers with tips that were anchored to focal adhe-
sions (FAs, indicated by p-Paxillin+) in dox-untreated cells (Fig-
ure 5D, left). After AKAP-Lbc-depletion, the actin fibers were
thinner and more disorganized and showed much less FA
anchoring (Figure 5D, right). Using live imaging, we found that
the well-developed actin meshwork was gradually shifted to
the less contractile fibers (Figure 5E and Movie S5, part 3).
To examine the relationship between actin dynamics, YAP/
TAZ, and hESC expansion, we tested simultaneous depletion
of AKAP-Lbc and cofilin, a major F-actin severing factor (Fig-
ure 5F) (Aragona et al., 2013). Immunostaining showed that cofi-
lin codepletion rescues stress fiber formation and FA-dependent
signal initiation (Figures 5G and S5B). Interestingly, the impaired
colony expansion in AKAP-Lbc-depleted cells was partially
reversed by cofilin suppression (Figures 5H, 5I, and S5C).
Consistent with this result, the reduced transcription of YAP/
TAZ target genes and the decreased nuclear YAP/TAZ is also
restored significantly (Figures 5J and 5K). These data suggested
a causal relationship between altered actin dynamics, YAP/TAZ
attenuation and impaired hESC expansion. Actin dynamics thus
provides amechanistic link connecting AKAP-Lbc/Rho signaling
to YAP/TAZ nuclear function.
Taken altogether, these data indicate that a Rho-mediated
survival pathway that consists of an AKAP-Lbc/Rho/F-actin
molecular cascade supports hESC survival and expansion by
promoting nuclear activity of YAP/TAZ (Figure 5L).c-Depleted hESCs
XL) were used to preserve the AKAP-Lbc-depleted population.
2 and CTGF.
ere treated with dox or not for 3 days.
ES-1 cells. The HSC70 was examined as a loading control.
tained with an antibody that recognizes both YAP and TAZ (green). The images
ed views squared in the upper images. The scale bar represents 50 mm.
ssing.
shCont, tet-shYAP (for inducible depletion of YAP), tet-shTAZ (for inducible
P and TAZ), were treated or not with dox for 3 days. The HSC70 was examined
s (I). The scale bar represents 500 mm.
f dox-treatment. The dead cells were visualized with YOYO-1 uptakes (green,
ys. The Bcl-XL-expressing cells (referred as a tet-shYAP/TAZ:Bcl-XL) were also
(n = 3) versus lane 2 (I); Tukey’s test (n = 3) among all groups (K); **p < 0.01; and
Figure 4. Hippo-OFF and TAZ-ON Experiments on AKAP-Lbc-Depleted hESCs
(A) Overview of the Hippo-mediated inhibition of YAP/TAZ. The Hippo-pathway activation results in LATS-mediated YAP/TAZ phosphorylation. The phos-
phorylated form of YAP/TAZ is sequestered in cytosol or degraded by proteasome.
(B) Western blotting analyses of components of the Hippo pathway. The tet-shLbc:Bcl-XL KhES-1 cells were cultured with or without dox for 3 days. The HSC70
was shown as a loading control.
(C) In vitro kinase assay for endogenous LATS2. As a negative control, immunoprecipitation was performed using an IgG antibody. The quantitative changes in
YAP phosphorylation were determined by each signal intensity and were shown as relatives to lane 1.
(legend continued on next page)
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Coordination of the Rho-Mediated Pathway and
Molecular Circuit of hESCs
Having shown that hESCs depend on the AKAP-Lbc/Rho
pathway for survival, we sought to investigate the potential rele-
vance of this phenotype for the pluripotent stem cell state.
By profiling the expression of key factors of the Rho-survival
signaling pathway, AKAP-Lbc, RhoC, and YAP/TAZ, in several
human cell lines, we found that they are present in all cell
lines examined (Figure S6A). We also confirmed that their
expression exhibited minor fluctuation during differentiation
of pluripotent cells into either endoderm or neuroectoderm
lineages (Figure S6B). Thus, expression of these factors does
not appear to be restricted to pluripotent cell types. However,
the cellular responses to AKAP-Lbc-depletion were dramati-
cally different: cell death occurred in human iPSC (253G1)
and mouse ESC (EB5) lines, but not in human carcinoma
HeLa cells or human dermal fibroblasts (HDFs) (Figures 6A–
6D). This suggests that dependence on AKAP-Lbc/Rho
signaling is a specific characteristic of ESCs/iPSCs, but is
not determined by cell-type specific transcriptional control of
pathway components.
How then is this cell-type specificity accomplished? We
hypothesized that cell identity is relevant and tested this pos-
sibility by shuffling cell identity via gain- or loss-of-pluripotency
experiments. In the gain-of-pluripotency studies, HDFs were
converted to a hESC-like state by cellular reprogramming
methods (Figures 6E and S6D), while in the loss-of-pluripo-
tency assay, hESCs were differentiated into retinal pigmented
epithelial-like cells (RPELCs), as a representative example of
hESC-derived differentiated somatic cells (Figures 6F, S6G,
and S6H). Interestingly, HDFs became vulnerable to AKAP-
Lbc-depletion-induced cell death after they were reprog-
rammed (Figures 6G, S6E, and S6F), while the hESC-derived
somatic cells could survive when AKAP-Lbc was depleted
(Figure 6I). To further characterize the apparent correlation
between cellular identity and survival dependency on this
Rho pathway, AKAP-Lbc was depleted during a specific
period of reprogramming process (Figure S6I), showing that
AKAP-Lbc-depletion during the later phase (day 8 onward)
substantially impaired the emergence of AP+ colonies (Figures
6H and 6I). These findings provide evidence that cellular differ-
entiation state, controls the phenotypic response to AKAP-
Lbc-depletion.
Together, these data suggest that human pluripotent stem
cell survival is intrinsically directed by the coordinated action
of an AKAP-Lbc/Rho pathway and the pluripotent cell state
(Figure 6J). The hESC-specific transcription factor circuit,
which is already regarded as critical for pluripotency mainte-
nance, may also play an important role in conferring immortality
on hESCs.(D) Western blotting analyses. The engineered KhES-1 cells, referred to as tet-shC
LATS1, and LATS2), were cultured with or without dox for 3 days. The HSC70 w
(E and F) Colony expansion assay (E) and area occupancy of AP-positive colonie
(G) qPCR assay for the YAP/TAZ target genes. The indicated cells were cultured
(H–K) Colony expansion assays. The tet-shLbc (H and I) or tet-shLbc/Lats KhES-
(indicated as tet-shLbc:TAZ, tet-shLbc:ERT2-TAZ, tet-shLbc/Lats:TAZ, and tet-sh
from day 2 to 5. The scale bar represents 500 mm. (I and K) Area occupancy of A
The bars in the graphs represent SD. Tukey’s test (n = 3) among all groups (F, G,
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Rho-Mediated Survival Signaling Pathway for hESC
Expansion
Sustained growth in vitro is a characteristic of hESCs. In this
study, we showed that Rho activity is essential for this capacity
of hESCs when they are grown as colonies. This finding may
seem somewhat paradoxical considering the known pro-
apoptotic function of Rho/ROCK signaling in dissociated hESCs
(Ohgushi et al., 2010). A striking difference, however, between
these two pathways is the GEF factors involved: ABR for pro-
apoptotic signaling in dissociated cells and AKAP-Lbc for pro-
survival signaling in colonies, which function non-redundantly
in the two different situations. In addition, ROCK has no effect
on hESC viability in colonies, and forced activation of TAZ
(LATS knock down + nuclear TAZ overexpression) does not pre-
vent dissociation-induced cell death (data not shown). Thus, two
functionally distinct Rho pathways seem to be independently
activated in hESCs depending on the intercellular adherence
status (clumping versus dissociation) and the presence or
absence of connecting neighbor cells.
When looking to understand the downstream components of
the Rho-mediated survival pathway, we identified a role of sus-
tained nuclear activity of YAP/TAZ, transcriptional cofactors
known as effector of the Hippo pathway. Consistent with the
cell contact-induced activation model, the Hippo pathway was
activated within hESC colonies and phosphorylated YAP/TAZ
in a contact-dependent fashion. Nevertheless, YAP/TAZ was
shown to be functionally active in this context, indicating an un-
expected decoupling of LATS-mediated phosphorylation and
YAP/TAZ function in which, although it is always primed for inac-
tivation, YAP/TAZ is able to escape from cytosolic sequestration
and degradation. A series of loss- and gain-of function studies
suggested that AKAP-Lbc/Rho signals render YAP/TAZ refrac-
tory to these regulatory surveillances. We showed that the
AKAP-Lbc/Rho/F-actin molecular cascade functions as a deter-
ministic upstream controller of YAP/TAZ and is dominant over
other counteracting upstream signaling, including cell-contact/
Hippo signals (Figure 5L). Recent related works revealed that
YAP/TAZ influenced cytoskeleton architecture (Morikawa et al.,
2015; Porazinski et al., 2015). In addition, it has been reported
that in some situations LATS regulates polarized accumulation
of F-actin (Ferna´ndez et al., 2011; Lucas et al., 2013). Thus, the
Hippo pathway, the cytoskeleton, and YAP/TAZ may form a
complex molecular network via multilayered interactions with
feedback mechanisms. How these are integrated to allow
YAP/TAZ nuclear accumulation and sustained hESC expansion
within high-density colonies, an unfavorable condition for cell
survival and proliferation, remains an interesting question for
future work.ont, tet-shLbc, and tet-shLbc/Lats (for triple inducible depletion of AKAP-Lbc,
as shown as a loading control.
s (F). The scale bar represents 500 mm.
with or without dox for 3 days.
1 cells (J and K) were engineered to express a wild-type or an ERT2-fused TAZ
Lbc/Lats:ERT2-TAZ, respectively). For TAZ activation, 4-OHT (1 mM)was added
P-positive colonies.
I, and K); not significant (n. s.); **p < 0.01; and ***p < 0.001. See also Figure S4.
(legend on next page)
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Plastic Immortality in Culture
In this study, we showed that a specific Rho signaling pathway
governs hESC survival. Dependency on this signaling pathway
for survival seems to be restricted to pluripotent cells. In addi-
tion, mouse genetic studies revealed that neither Akap13 nor
Rhoc is required for survival of pluripotent cells in vivo (Hakem
et al., 2005; Mayers et al., 2010). This finding supports the hy-
pothesis that the molecular pathways presented here are specif-
ically required for PSC survival in vitro.
In general, cells derived from animals are difficult to grow and
maintain in vitro, as they readily undergo senescence or death in
culture. However, ES and tumor cells are special exceptions to
this rule. In contrast to tumor-derived cells, ESCs show charac-
teristic reversibility of their immortality during differentiation. As
YAP/TAZ is a potent driver of proliferation and survival, we
reasoned that sustained nuclear activity of YAP/TAZ, which can
otherwise drop in response to various stimuli (e.g., cytoskeletal
reorganization), represents one critical mechanism ensuring the
reversible immortalized phenotype of hESCs. On the other
hand, YAP/TAZ are considered as ‘‘stemness factors’’ in several
types of stem cells (Tremblay and Camargo, 2012) and in ESCs
they have been incorporated into the transcriptional circuit for
pluripotency (Varelas et al., 2008; Lian et al., 2010; Beyer et al.,
2013, and our unpublished data). Notably, when cell death is cir-
cumvented, prolonged AKAP-Lbc-depletion causes correlated
changes in differentiation-associated marker expression (data
not shown), suggesting the interesting possibility that the
AKAP-Lbc/Rho signaling modulates the integrity of self-renewal
and survival competency by regulating the dual action of YAP/
TAZ as stemness and survival factor. Within this molecular
framework, YAP/TAZ stands at the crossroads of two essential
modules underlying hESC identity: a Rho-mediated survival
signal and a transcriptional network supporting the maintenance
of pluripotency (Figure 6J). In this system, the survival signal input
branches to stabilize the network, while the stemness-associ-
ated circuit underpins YAP/TAZ-driven expansion of these
untransformed cells. This coordinated feedback may serve to
safeguard the robustness of these striking properties of hESCs.Figure 5. Actin Dynamics Links AKAP-Lbc/Rho Signal to YAP/TAZ Fun
(A) Live imaging analyses of the dox-treated tet-shLbc:Bcl-XL KhES-1 cells. The d
was started from 24 hr after dox addition. The scale bar represents 200 mm.
(B) F-actin staining (green) in the tet-shLbc:Bcl-XL KhES-1 cells treated with dox
confocal images are shown. The upper and bottom images are the x-y and x-z v
(C) Schematic diagram of morphological transformation upon AKAP-Lbc-depleti
(D) Immunostaining of basal actin meshwork. The tet-shLbc:Bcl-XL KhES-1 cells
confocal microscopy. The F-actin (green) and phospho-Paxillin (red) are shown. Th
bar represents 10 mm.
(E) Live imaging analyses of the dox-treated or untreated tet-shLbc:Bcl-XL KhES
mCherry, respectively. The recording was started from 24 hr after dox addition.
(F and G) The engineered KhES-1 cells, indicated as tet-shCont, tet-shLbc, and
cultured with or without dox for 3 days.
(F) Western blotting analyses. The HSC70 was a loading control.
(G) Immunostaining for basal actin meshwork. The F-actin (green) and phospho-P
The scale bar represents 50 mm.
(H and I) Colony expansion assay (H) and area occupancy of AP-positive colonie
(J and K) YAP/TAZ localization and function. The indicated cells were cultured w
(green). The images were obtained using a confocal microscopy. The scale bar r
(L) Signaling network of the Rho-mediated survival pathway.
The bars in the graphs represent SD. Tukey’s test (n = 3) among all groups (I and
Movie S5.
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derivation remains an open question. A report that genomic
lesion-free immortality was induced during the conversion of so-
matic cells, including peripheral blood cells, to a pluripotent state
may provide a fruitful hint for this question (Okita et al., 2013). In
the present study, we provide data suggesting that AKAP-Lbc
was required for the efficient propagation of reprogrammed cells
(Figures 6H and 6I), which is in line with the reported positive
roles of YAP and TAZ in reprogramming (Lian et al., 2010; Qin
et al., 2012). Another hallmark shared by AKAP-Lbc and YAP/
TAZ is that they are known oncoproteins whose hyperactivation
can immortalize primary cells (Onco-Lbc, a constitutively active
mutant of AKAP-Lbc, was originally identified in human leuke-
mia; Figure S2D; Zheng et al., 1995). Together, our findings sug-
gest the possibility that the AKAP-Lbc/Rho-mediated promotion
of YAP/TAZ activation is conducive to the generation of ESCs/
iPSCs by reversibly activating the intrinsic program for the estab-
lishment of in vitro immortality.
Although successful ex vivo cultivation and scalable expan-
sion is currently restricted to a few types of stem/progenitor cells
(Wang et al., 2015; Huch et al., 2015), it will be important to test
the potential for application of this technology to a broader range
of cells. A deeper understanding of the molecular basis of the
intrinsic immortality of ESCs/iPSCs could help to provide funda-
mental insights useful for addressing the practical challenge of
maintaining viability across a variety of different cell types.EXPERIMENTAL PROCEDURES
Cell Culture
All experiments using hESC lines were approved by an institutional ethics
committee and done following the hES cell guidelines of the Japanese govern-
ment. The hESC (KhES-1 and KhES-3) and hiPSC lines (253G1 and in-house
lines) were maintained as described previously (Watanabe et al., 2007). They
were cultured on feeder layers of mouse embryonic fibroblasts (MEF) in
DMEM: nutrient mixture F-12 (DMEM/F12) (Sigma) supplemented with 20%
knockout serum replacement (KSR), 2 mM glutamine, 0.1 mM non-essential
amino acids (Invitrogen), 5 ng/ml recombinant human bFGF (Wako), and
0.1 mM 2-mercaptoethanol (2-ME). For feeder-free condition, cells werection
ead cells were validated with YOYO-1 uptakes (green, bottom). The recording
or not for 3 days. The snapshots of 3D reconstitution displays from z series of
iews, respectively. The scale bar represents 50 mm.
on. The illustrations show side-views of the colony.
were treated with dox or not for 3 days. The basal surface was imaged with
e bottom images show enlarged views squared in the upper images. The scale
-1 cells. The F-actin and FA were visualized by Lifeact-mVenus and Paxillin-
tet-shLbc/Cfl (for double inducible depletion of AKAP-Lbc and cofilin), were
axilin (red) were shown. The images were obtained with a confocal microscopy.
s (I). The scale bar represents 500 mm.
ith or without dox for 3 days (J). The immunostaining for YAP/TAZ is shown
epresents 50 mm. (K) qPCR assay for the YAZ/TAZ target genes.
K); not significant (n. s.); **p < 0.01; and ***p < 0.001. See also Figure S5 and
Figure 6. Cellular Identity Dictates Survival Dependency on the Rho Signaling
(A–D) Human iPSCs (253G1), mouse ESCs (EB5), HeLa, and HDFs were engineered for conditional knock down of AKAP-Lbc (indicated as 253G1:tet-shLbc,
EB5:tet-shLbc, HeLa:tet-shLbc, and HDF:tet-shLbc, respectively). These cells were cultured with or without dox for 3 days (for western blotting analyses and cell
death assay) or 5 days (for colony expansion assay). (A and C) Western blotting analyses for AKAP-Lbc. The HSC70 was a loading control. (B) Colony expansion
assay. (D) Cell death assay. For a positive control, 253G1:tet-shLbc hiPSCs were also examined.
(E–G) Gain- and loss-of-pluripotency experiments. (E) The tet-shLbc HDFs (top) were reprogrammed by iPS technology (indicated as a HDF-iPSC:tet-shLbc,
clone 1 was shown). The differential interference contrast (DIC) and immunostaining images for pluripotent markers, NANOG (green), and SSEA-3 (red) are shown
(bottom). (F) KhES-1 cells (top) were differentiated into somatic-like cells positive for RPE markers, RAX (green), and MITF (red) (bottom) and then they were
engineered for the conditional knock down of AKAP-Lbc (indicated as RPELC:tet-shLbc). Western blotting analyses are shown for the further confirmation of cell
state conversion. The actin was examined as a loading control. (G) Cell death assay. The indicated cells were cultured with or without dox for 3 days. The scale
bars represent 200 mm.
(H and I) Effects of AKAP-Lbc-depletion on reprogramming. The transfectants were divined into two dishes on day 7 and from day 8 the cells were cultured in the
presence or absence of dox (0.1 mg/ml).
(legend continued on next page)
Cell Stem Cell 17, 448–461, October 1, 2015 ª2015 Elsevier Inc. 459
cultured on Matrigel substrates (Invitrogen) in MEF-conditioned medium or
mTeSR1 medium (STEMCELL Technologies).
Gene Manipulation
The plasmid transfection was performed as described previously (Ohgushi
et al., 2010). To obtain stable transfectants, the cDNA expression cassettes
were integrated into genomes using a PiggyBac transposon system. A few
days after transfection, stable transfectants were selected by drug treatment.
To avoid clone biases, a drug-resistant pool was used for experiments without
single cell-derived colony pick-up. For an inducible gene silencing, we used
dox-inducible shRNA expression lentivirus vectors. For amore detailed outline
of the strategy for double or triple knockdown and target mRNA sequences,
see Supplemental Information.
Colony Expansion Assay, Immunostaining, and Biochemical
Analyses
For colony expansion assay, cells were dissociated and seeded onto MEF-
coated 12 well plates in the presence of 10 mM Y-27632. After complete
Y-27632 removal on the next day, cells were cultured for 24 hr to form small
colonies. Using this strategy, we succeeded in reproducibly making small col-
onies with uniform size and equal cell numbers in each well. At 2 days after
seeding, 1 mg/ml of dox was added and the colonies were further cultured
for 5 days with daily media changes. Undifferentiated colonies were visualized
by AP staining. Immunostaining was performed as previously described
(Watanabe et al., 2007). For western blot analyses, cells were once transferred
onto the Matrigel-coated dishes before being lysed. For a complete list of
antibodies used in this work, see Supplemental Information.
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